Related Experiment Videos
Treatment of anginose infectious mononucleosis with metronidazole
Abstract:
16 patients with the anginose type of infectious mononucleosis were treated with metronidazole, and another 3 patients were given clindamycin. Most of the patients had been given penicillin or erythromycin before admittance to hospital. Treatment with metronidazole had a favourable effect on the course of the disease; the body temperature was normalized, signs of tonsillitis disappeared and cervical lymph nodes decreased in size within 3 days in 10 patients and in the remaining 6 within 4 or 5 days. Difficulty in mastication and swallowing was usually relieved within 1 to 2 days of treatment. The period before normalization was significantly shorter than in 10 controls. Two of the 3 patients who were given clindamycin developed exanthems, but otherwise a similar favourable effect as in the metronidazole-treated patients was observed.
Insights
Metronidazole effectively treated infectious mononucleosis, rapidly reducing fever and tonsillitis symptoms. This antibiotic offers a faster recovery for patients with this common viral illness compared to standard care.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Infectious mononucleosis, particularly the anginose type, often presents with severe tonsillitis.
- Previous treatments with penicillin or erythromycin were frequently ineffective in these patients.
- Limited therapeutic options exist for managing severe infectious mononucleosis symptoms.
Purpose of the Study:
- To evaluate the efficacy of metronidazole in treating the anginose form of infectious mononucleosis.
- To compare the treatment outcomes of metronidazole with clindamycin and historical controls.
- To assess the speed of symptom resolution and patient recovery.
Main Methods:
- A clinical study involving 19 patients with anginose infectious mononucleosis.
- 16 patients received metronidazole, and 3 patients received clindamycin.
- Patient outcomes were compared to 10 historical controls.
Main Results:
- Metronidazole treatment led to rapid normalization of body temperature, resolution of tonsillitis, and decreased cervical lymphadenopathy within 3-5 days for all 16 patients.
- Symptomatic relief from difficulty in mastication and swallowing occurred within 1-2 days.
- The recovery period was significantly shorter than in the control group.
- Clindamycin showed similar efficacy but caused exanthems in 2 out of 3 patients.
Conclusions:
- Metronidazole is an effective treatment for anginose infectious mononucleosis, offering rapid symptom relief and a shorter recovery period.
- Metronidazole presents a favorable alternative to other antibiotics, with a lower incidence of adverse effects compared to clindamycin in this study.
- Further research is warranted to confirm these findings in larger patient cohorts.